I’m Sofia, and I suffer from Alzheimer’s Disease

I am a woman of 40 years, who has been impacted by Alzheimer’s Disease for more than half of my life. My grandmother was buried during my first year and the autopsy showed Alzheimer’s. When I was just a young teenager, my father was affected by the disease and eventually died in 1999. His brother died seven years after with the same disease.

I am thus committed to educate people about the Alzheimer’s Disease. With money from the Swedish Alzheimer Association I was able together with two other persons to make a film about being young and related to this disease.

I could not have imagined that seventeen years after my father’s death, I would receive the news that I was affected as well. Unfortunately, I had to struggle at first as believed by doctors. When I passed most of the standardized tests, the doctors said that it was nothing to be worried about. I had to change doctors twice but I finally got the help when I got in contact with my father’s old retired doctor, and move to the area where I lived when my father was still alive to get help. While the medical investigation was going on, I studied to be a health educator and managed a three-year education at the university.

I will be writing about the many challenges of young-onset Alzheimer’s patients, and especially women’s encounters.

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.